DePuy Synthes Products, Inc.Download PDFPatent Trials and Appeals BoardJul 1, 20212020006647 (P.T.A.B. Jul. 1, 2021) Copy Citation UNITED STATES PATENT AND TRADEMARK OFFICE UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 15/013,172 02/02/2016 Jean-Noel Bordeaux 104525.007022 1356 53443 7590 07/01/2021 BakerHostetler Cira Centre, 12th Floor 2929 Arch Street Philadelphia, PA 19104-2891 EXAMINER PRONE, CHRISTOPHER D ART UNIT PAPER NUMBER 3774 NOTIFICATION DATE DELIVERY MODE 07/01/2021 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address(es): eofficemonitor@bakerlaw.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE ____________ BEFORE THE PATENT TRIAL AND APPEAL BOARD ____________ Ex parte JEAN-NOEL BORDEAUX and TIMOTHY J. HORAN Appeal 2020-006647 Application 15/013,172 Technology Center 3700 ____________ Before JENNIFER D. BAHR, EDWARD A. BROWN, and MICHAEL J. FITZPATRICK, Administrative Patent Judges. FITZPATRICK, Administrative Patent Judge. DECISION ON APPEAL Appellant, DePuy Synthes Products, Inc.,1 appeals under 35 U.S.C. § 134(a) from the Examiner’s final decision rejecting claims 1–4, 6, 12–16, 19, 20, and 27–29. Final Act. 1. We have jurisdiction under 35 U.S.C. § 6(b). We affirm. 1 “Appellant” refers to the applicant as defined in 37 C.F.R. § 1.42. Appellant identifies itself as the sole real party in interest and discloses that it is “a Johnson & Johnson company.” Appeal Br. 1. Appeal 2020-006647 Application 15/013,172 2 STATEMENT OF THE CASE The Specification Appellant’s disclosure relates “to systems, apparatus, and methods for performing a tibial tuberosity advancement procedure.” Spec. ¶2. The Claims Claims 1–4, 6, 12–16, 19, 20, and 27–29 are rejected. Final Act. 1; Ans. 3. Claims 24–26 are withdrawn from consideration. Final Act. 1. Claims 21–23, 30, and 31 were rejected in the Final Action, but their rejection has been withdrawn. Final Act. 1; Ans. 3. Claim 1 is the sole independent claim on appeal. Appeal Br. A1–A2. It is illustrative and reproduced below. 1. A tibial tuberosity advancement system configured to maintain a tuberosity, that has been moved cranially from an initial position to an advanced position relative to a tibial body, in the advanced position, the tibial tuberosity advancement system comprising: an implant including an implant body, the implant body defining a proximal end portion, a distal end portion, and an intermediate portion that extends between the proximal end portion and distal end portion, the intermediate portion shaped such that when the distal end portion is attached to the tibial body, a first surface of the proximal end portion faces the tuberosity, a second surface of the proximal end portion is opposite the first surface the implant body defining a fastener hole that extends through the proximal end portion along a central axis that is nonparallel with respect to a direction normal to the first surface; a spacer configured and sized to fit at least partially within a gap disposed between the tuberosity and the tibial body when the tuberosity is in the advanced position, the spacer including a spacer body and a slot that extends through the spacer body; and Appeal 2020-006647 Application 15/013,172 3 a spacer fixation member that includes a first end portion configured to be attached to the tuberosity, a second end portion that is configured to be attached to the tibial body, and an intermediate fixation portion that extends between the first end portion and the second end portion, the intermediate fixation portion configured and sized to be at least partially received in the slot so as to couple the spacer fixation member to the spacer. Id. The Examiner’s Rejections The following rejections, both pursuant to 35 U.S.C. § 103, are before us: (1) claims 1–4, 6, 12, 19, 20, and 27–29 as unpatentable over Lafaver2 and Medoff3 (Final Act. 3; Ans. 3); and (2) claims 13–16 as unpatentable over Lafaver, Medoff, and Gall4 (Final Act. 4). DISCUSSION Appellant argues against both rejections, and with respect to all rejected claims, on the basis of purported error in the rejection of claim 1. Appeal Br. 15–18.5 2 Sarah Lafaver et al., Tibial Tuberosity Advancement for Stabilization of the Canine Cranial Cruciate Ligament-Deficient Stifle Joint: Surgical Technique, Early Results, and Complications in 101 Dogs, 36 VETERINARY SURGERY 573–86 (2007) (“Lafaver”). 3 US 6,077,266, issued June 20, 2000 (“Medoff”). 4 US 2008/0269808 Al, published Oct. 30, 2008 (“Gall”). 5 Appellant also presented arguments specific to independent claim 21 and dependent claims 22, 23, 30, and 31 (Appeal Br. 18–20), but the Examiner ultimately withdrew the rejection of those claims. Ans. 3. Appeal 2020-006647 Application 15/013,172 4 The Examiner found that Lafaver discloses the subject matter of claim 1 save “a fastener hole that extends through the proximal end portion along a central axis that is nonparallel with respect to a direction normal to the first surface,” as recited in claim 1. Final Act. 3 (citing Lafaver Figs. 1 and 5C). Lafaver discloses fastener holes that extend through a proximal end portion but does not describe them as angled. Lafaver Fig. 1 (refs. 2–8). However, the Examiner found that “Medoff teaches the use of bone plate implants comprising through hole sections with angled openings non- parallel to a direction normal to the surface for the purpose of guiding bone screws or pins into the desired final orientation.” Final Act. 3; see also Ans. 4–6 (citing Medoff Figs. 1–2). The Examiner concluded: It would have been obvious to one having ordinary skill in the art at the time the invention was made to modify the holes of the implant body of Lafaver to be angled in the same orientation as the fasteners as taught by Medoff in order to better guide the fasteners and prevent any jamming or sticking. Final Act. 3–4. Appellant argues against the rejection but does so, in part, by mischaracterizing the Examiner’s proposed modification of Lafaver in an attempt to show error in the Examiner’s reasoning for the modification. More specifically, Appellant argues: The Examiner cites Medoff for teaching a bone plate having screw holes that are configured to receive bone screws to attach to an underlying fractured bone to assist with bone healing (See Col. 1, lines 1–45, Col. 2, lines 10–16, and claim 1). The Examiner attempts to replace the apertures of Lafaver’s implant that receive fork and pegs with the screw holes of Medoff. However, in doing so, the Examiner has failed to establish a credible motivation why one having ordinary skill in the art would modify the first portion of Lafaver’s implant that attaches Appeal 2020-006647 Application 15/013,172 5 to the tuberosity with Medoff’s screw holes, as opposed to the second portion that attaches to the tibia and in fact defines bone screw holes. As noted above, Lafaver’s second portion that attaches to the tibia is the only portion of Lafaver’s implant that is disclosed as including bone screw holes that are configured to receive bone screws. Appeal Br. 16. But the Examiner did not propose to replace Lafaver’s apertures with screw holes. The Examiner proposed modifying the existing apertures in Lafaver’s proximal portion to make them angled to match the angle of the pegs/tines/pins.6 Final Act. 3–4; Ans. 4 (“[I]t would have been obvious to modify the openings of Lafaver receiving the angled pins, to have an angled orientation.”). And the Examiner provides an adequate reason based on the prior art: “in order to guide the pins to a desired consistent angle and to prevent any jamming or sticking during the insertion process.” Ans. 4. As the Examiner further notes: When a pin or a plurality of pins all need to be inserted at the same angle [as in Lafaver] it would have been obvious to utilize an opening angled to the same degree. Medoff specifically teaches that it is old and well known in the art of bone plates to modify the opening of a plate to match the desired insertion angle of the fastener extending there through. Ans. 4. 6 All three terms—pegs, tines, and pins—are used in the record before us to refer to the same structure disclosed in Lafaver: the angled insertion structures illustrated in Figure 1 of Lafaver. See Appeal Br. 15 (“The first portion [of Lafaver] is secured to the tuberosity by inserting pegs of a fork through apertures that extend through the first portion”); Aug. 27, 2019, Advisory Act. (“[T]he holes of Lafaver are not angled to the same orientation as the tines.”); Ans. 4 (“Lafaver specifically discloses that the fastener pins all should be inserted at an angle.”). Appeal 2020-006647 Application 15/013,172 6 With respect to the actual modification proposed by the Examiner, Appellant appears to argue that the prior art teaches away from it. In that regard, Appellant argues “changing the orientation of the Lafaver’s apertures that receive the pegs of the fork [to] better guide the fasteners and prevent any jamming or sticking . . . run[s] contrary to the explicit teachings of Lafaver.” Appeal Br. 16. The explicit teaching identified by Appellant is the following: “Note that the central peg of the fork has a notch to match the smaller square central hole of the plate to snap both pieces together.” Lafaver 576 (Fig. 4D caption) (bold typeface omitted). But Appellant’s argument is not persuasive. That the fork and proximal portion are snapped or locked together once they are in the desired mated configuration is quite different than whether they get stuck or jammed during mating and in an undesired configuration. It is for purposes of avoiding the latter that the Examiner reasons a person of ordinary skill in the art would have made the proposed modification. And the Examiner makes this abundantly clear in the Answer. See Ans. 4 (“[I]t would have been obvious to modify the openings of Lafaver receiving the angled pins, to have an angled orientation in order to guide the pins to a desired consistent angle and to prevent any jamming or sticking during the insertion process.” (emphasis added)). And as the Answer points out, the proposed modification does not preclude maintaining a notch on a peg so that the peg can retain its snap lock fit. Ans. 4. To the extent that the angled opening might interfere with the snap lock fit—as Appellant argues (Appeal Br. 17)—a person of ordinary skill in the art would know how to compensate for the angling of the aperture to retain a snap lock fit, for example, by similarly angling the notch. See KSR Int’l Co. v. Teleflex Inc., 550 U.S. 398, 421 Appeal 2020-006647 Application 15/013,172 7 (2007) (“A person of ordinary skill is also a person of ordinary creativity, not an automaton.”). Appellant describes Lafaver’s apparatus as a “specialized implant designed to achieve a specific type of fixation (tibial and advanced tuberosity).” Appeal Br. 17. Appellant argues that, despite being “aware of bone screw fixation technology [and] angulating fixation members,” “Lafaver intentionally . . . maintains the normal orientation of the apertures [and] ensures that the central aperture is sufficiently small to ensure attachment of the implant to the fork.” Id. This argument is not persuasive that the Examiner’s proposed modification would not have been obvious. First, the test is not what Lafaver and her co-authors would have found obvious. It is what would have been obvious to a hypothetical person of ordinary skill in the art. See In re Rouffet, 149 F.3d 1350, 1357 (Fed. Cir. 1998) (“Obviousness is determined from the vantage point of a hypothetical person having ordinary skill in the art to which the patent pertains.”). Second, the Examiner’s proposed modification need not be the best solution to be an obvious solution. See PAR Pharm., Inc. v. TWI Pharms., Inc., 773 F.3d 1186, 1197–98 (Fed. Cir. 2014) (“Par also argues that there were better methods available to address the viscosity and interpatient variability concerns with Megace OS. Our precedent, however, does not require that the motivation be the best option, only that it be a suitable option from which the prior art did not teach away.”); In re Fulton, 391 F.3d 1195, 1200 (Fed. Cir. 2004) (“[A] finding that the prior art as a whole suggests the desirability of a particular combination need not be supported by a finding that the prior art suggests that the combination claimed . . . is the preferred, or most desirable, combination.”). Appeal 2020-006647 Application 15/013,172 8 Appellant does not apprise us of error in the rejection of claim 1. Accordingly, we affirm the rejection of claim 1. In addition, because Appellant does not present separate arguments for any other rejected claim, we likewise affirm the rejection of claims 2–4, 6, 12, 19, 20, 27–29 and the rejection of claims 13–16. SUMMARY Claim(s) Rejected 35 U.S.C. § Reference(s)/ Basis Affirmed Reversed 1–4, 6, 12, 19, 20, 27– 29 103 Lafaver, Medoff 1–4, 6, 12, 19, 20, 27– 29 13–16 103 Lafaver, Medoff, Gall 13–16 Overall Outcome 1–4, 6, 12– 16, 19, 20, 27–29 No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a). See 37 C.F.R. § 1.136(a)(1)(iv) (2019). AFFIRMED Copy with citationCopy as parenthetical citation